欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3154/001
药品名称Bortezomib Sandoz
活性成分
    • Bortezomib 3.5 mg
剂型Powder for solution for injection
上市许可持有人Sandoz B.V. Veluwezoom22 1327AH Almere
参考成员国 - 产品名称Netherlands (NL)
Bortezomib Sandoz 3,5 mg, poeder voor oplossing voor injectie
互认成员国 - 产品名称
    • Luxembourg (LU)
    • Estonia (EE)
    • France (FR)
    • Slovakia (SK)
    • Latvia (LV)
    • Czechia (CZ)
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • United Kingdom (Northern Ireland) (XI)
    • Portugal (PT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Hungary (HU)
    • Slovenia (SI)
    • Italy (IT)
许可日期2015/10/20
最近更新日期2024/12/12
药物ATC编码
    • L01XX32 bortezomib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase